Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Tomas G Nielan"'
Publikováno v:
Blood. 136:9-9
Introduction: CD19-targeting chimeric antigen receptor (CAR) T cell therapy has generated robust clinical responses in the treatment of relapsed and refractory hematological malignancies. While CAR T cell toxicity in the form of cytokine release synd